EyePoint Pharmaceuticals EYPT

$ 7.16 0.49%

Quarterly report 2024-Q3
added 11-07-2024

EyePoint Pharmaceuticals Cash and Cash Equivalents 2011-2024 | EYPT

Annual Cash and Cash Equivalents EyePoint Pharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
281 M	95.6 M	179 M	44.9 M	22.2 M	45.3 M	16.9 M	15.3 M	19.1 M	15.3 M	6.9 M	4.62 M	12.9 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
281 M	4.62 M	58.4 M

Quarterly Cash and Cash Equivalents EyePoint Pharmaceuticals

2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
79.8 M	90.8 M	281 M	133 M	140 M	106 M	95.6 M	75.4 M	82.1 M	102 M	179 M	120 M	128 M	139 M	44.9 M	44.9 M	44.9 M	44.9 M	22.2 M	22.2 M	22.2 M	22.2 M	45.3 M	45.3 M	45.3 M	45.3 M	12.9 M	11.8 M	16.9 M	16.9 M	11.7 M	14.3 M	11.7 M	14.3 M	11.2 M	14.1 M	11.2 M	14.1 M	29.8 M	11.4 M	29.8 M	11.4 M	15.2 M	14.5 M	15.2 M	14.5 M	9.41 M	8.39 M	9.41 M	8.39 M	8.41 M	9.81 M	8.41 M	9.81 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
281 M	8.39 M	47.7 M